Quantres Asset Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-35,625
Closed -$1.22M 222
2017
Q4
$1.22M Buy
35,625
+26,771
+302% +$913K 0.77% 38
2017
Q3
$300K Buy
+8,854
New +$285K 0.19% 151
2016
Q4
Sell
-31,093
Closed -$999K 223
2016
Q3
$999K Buy
31,093
+23,820
+328% +$796K 0.62% 57
2016
Q2
$243K Buy
+7,273
New +$232K 0.15% 151
2015
Q3
Sell
-12,964
Closed -$412K 175
2015
Q2
$412K Buy
+12,964
New +$423K 0.33% 98

Other funds holding PFE

Quantres Asset Management's PFE Position: Q1 2018 in Review

Quantres Asset Management sold out of Pfizer (PFE) in Q1 2018, closing a stake of 35,625 shares — an estimated $1.22M sold.

Quantres Asset Management first reported a position in PFE in Q2 2015 and held it in 5 quarters. The position peaked at $1.22M in Q4 2017. 2,229 funds tracked by Wall St. Rank hold PFE as of Q1 2018.

  • Quantres Asset Management reported no remaining Pfizer position as of Q1 2018 after selling out during the quarter.
  • Quantres Asset Management sold 35,625 Pfizer shares in Q1 2018, an estimated $1.22M.
  • Quantres Asset Management first reported a position in Pfizer in Q2 2015 and held it in 5 quarters.
  • Quantres Asset Management's Pfizer position peaked at $1.22M in Q4 2017.
  • 2,229 funds tracked by Wall St. Rank held Pfizer as of Q1 2018.

Based on Quantres Asset Management's 13F filing for Q1 2018, filed 3 May 2018.